当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-03 , DOI: 10.1038/nrclinonc.2017.210 Peter Sidaway
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-01-03 , DOI: 10.1038/nrclinonc.2017.210 Peter Sidaway
Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors
中文翻译:
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应
更新日期:2018-01-03
Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors, Published online: 03 January 2018; doi:10.1038/nrclinonc.2017.210
Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors中文翻译:
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应,在线发布:2018年1月3日; doi:10.1038 / nrclinonc.2017.210
免疫疗法:HLA-1基因型影响对检查点抑制剂的反应